{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:40:00Z","timestamp":1785577200005,"version":"3.56.0"},"reference-count":42,"publisher":"American Veterinary Medical Association (AVMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To investigate effects of IV administration of propafenone for naturally occurring and experimentally induced chronic atrial fibrillation in horses.<\/jats:p>\n<jats:p><jats:bold>Animals<\/jats:bold>\u20142 horses with naturally occurring atrial fibrillation and 4 horses with pacing-induced atrial fibrillation.<\/jats:p>\n<jats:p><jats:bold>Procedures<\/jats:bold>\u2014Horses received a bolus of propafenone (2 mg\/kg, IV over 15 minutes). If atrial fibrillation persisted after 20 minutes, a continuous infusion of propafenone (7 \u03bcg\/kg\/min) was given for 120 minutes. Before, during, and after treatment, plasma propafenone concentrations, hematologic and serum biochemical values, and electolyte concentrations analyses were determined and clinical signs were monitored. Surface ECGs were recorded. If propafenone treatment failed, quinidine sulfate was administered.<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014Bolus and continuous infusion induced minimal adverse effects. During the 15-minute bolus administration, a slight increase in heart rate was observed and horses appeared more sensitive to external stimuli. Throughout treatment, no significant changes were observed in respiratory rate, QRS or corrected QT duration, or results of hematologic analyses. Although a significant increase in F-wave interval and atrial fibrillation cycle length was observed and plasma propafenone concentrations (569 to 1,268 ng\/mL) reached the human therapeutic range (64 to 1,044 ng\/mL), none of the horses cardioverted to sinus rhythm. Sinus rhythm could be restored in all horses via standard oral administration of quinidine.<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014A slow IV bolus of 2 mg of propafenone\/kg followed by a continuous infusion of 7 \u03bcg\/kg\/min over 2 hours was not an effective treatment for chronic atrial fibrillation in horses.<\/jats:p>","DOI":"10.2460\/ajvr.70.2.223","type":"journal-article","created":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T13:31:30Z","timestamp":1233581490000},"page":"223-227","source":"Crossref","is-referenced-by-count":16,"title":["Use of propafenone for conversion of chronic atrial fibrillation in horses"],"prefix":"10.2460","volume":"70","author":[{"given":"Dominique","family":"De Clercq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther","family":"van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Verbesselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Deprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"J Am Vet Med Assoc","first-page":"261","article-title":"Atrial fibrillation in horses: a review of 106 clinical cases, with consideration of prevalence, clinical signs, and prognosis","volume":"180","author":"Deem","year":"1982"},{"key":"ref2","series-title":"Large animal internal medicine","first-page":"471","article-title":"Diseases of the cardiovascular system. Atrial fibrillation","author":"Reef","year":"2002"},{"key":"ref3","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1939-1676.1988.tb01970.x","article-title":"Factors affecting prognosis and conversion in equine atrial fibrillation","volume":"2","author":"Reef","year":"1988"},{"key":"ref4","series-title":"Atrial pacing and experimental atrial fibrillation in equines","first-page":"162","article-title":"Effects of experimental chronic atrial fibrillation in equines","author":"van Loon","year":"2001"},{"key":"ref5","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1939-1676.1995.tb03274.x","article-title":"Treatment of atrial fibrillation in horses: new perspectives","volume":"9","author":"Reef","year":"1995"},{"key":"ref6","series-title":"J Vet Med Sci","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1292\/jvms.62.711","article-title":"Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation","volume":"62","author":"Ohmura","year":"2000"},{"key":"ref7","series-title":"Equine Vet J","first-page":"609","article-title":"Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation","volume":"36","author":"van Loon","year":"2004"},{"key":"ref8","series-title":"Autumn Meet Vet Cardiovasc Soc","first-page":"2","article-title":"Methods of treatment and new management techniques in horses with AF, in Proceedings","author":"van Loon","year":"2003"},{"key":"ref9","series-title":"Vet J","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tvjl.2005.04.001","article-title":"Intravenous amiodarone treatment in horses with chronic atrial fibrillation","volume":"172","author":"De Clercq","year":"2006"},{"key":"ref10","series-title":"Equine Vet J","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2746\/042516407X182811","article-title":"Effects of an adapted intravenous amiodarone treatment protocol in horses with atrial fibrillation","volume":"39","author":"De Clercq","year":"2007"},{"key":"ref11","series-title":"J Vet Intern Med","first-page":"715","article-title":"Transvenous electrical cardioversion in equine atrial fibrillation: technique and successful treatment of 3 horses","volume":"5","author":"McGurrin","year":"2003"},{"key":"ref12","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2460\/javma.2002.220.1039","article-title":"Use of biphasic electrical cardioversion for treatment of idiopathic atrial fibrillation in two horses","volume":"220","author":"Frye","year":"2002"},{"key":"ref13","series-title":"J Vet Intern Med","first-page":"695","article-title":"Transvenous electrical cardioversion of equine atrial fibrillation: technical considerations","volume":"19","author":"McGurrin","year":"2005"},{"key":"ref14","series-title":"J Vet Cardiol","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jvc.2005.09.001","article-title":"How to perform transvenous electrical cardioversion in horses with atrial fibrillation","volume":"7","author":"McGurrin","year":"2005"},{"key":"ref15","series-title":"Vet J","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tvjl.2004.08.013","article-title":"Transient complete atrioventricular block following transvenous electrical cardioversion of atrial fibrillation in a horse","volume":"170","author":"van Loon","year":"2005"},{"key":"ref16","series-title":"Vet J","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tvjl.2007.08.019","article-title":"Transvenous electrical cardioversion of atrial fibrillation in six horses using custom made cardioversion catheters","volume":"177","author":"De Clercq","year":"2008"},{"key":"ref17","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0735-1097(98)00678-0","article-title":"Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study","volume":"33","author":"Kochiadakis","year":"1999"},{"key":"ref18","series-title":"Can J Vet Res","first-page":"254","article-title":"Pacing induced sustained atrial fibrillation in a pony","volume":"64","author":"van Loon","year":"2000"},{"key":"ref19","series-title":"Ther Drug Monit","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00007691-199103000-00012","article-title":"High-performance liquid chromatographic determination of 12 antiarrhythmic drugs in plasma using solid-phase column extraction","volume":"13","author":"Verbesselt","year":"1991"},{"key":"ref20","series-title":"Equine Vet J Suppl","first-page":"18","article-title":"Echocardiographic measurements of cardiac dimensions and indices of cardiac function in normal adult thoroughbred horses","volume":"19","author":"Patteson","year":"1995"},{"key":"ref21","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S0735-1097(00)01116-5","article-title":"Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation","volume":"37","author":"Khan","year":"2001"},{"key":"ref22","series-title":"Circulation","first-page":"e257","article-title":"ACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice guidelines","volume":"114","author":"Fuster","year":"2006"},{"key":"ref23","series-title":"Methods Find Exp Clin Pharmacol","first-page":"435","article-title":"Pharmacokinetics of intravenous propafenone in patients with episodes of paroxysmal supraventricular tachycardia","volume":"7","author":"Arboix","year":"1985"},{"key":"ref24","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/01.CIR.68.3.589","article-title":"Clinical pharmacology of propafenone","volume":"68","author":"Connolly","year":"1983"},{"key":"ref25","series-title":"Arzneimittelforschung","first-page":"763","article-title":"Investigations on the pharmacokinetics of propafenone in man","volume":"33","author":"Hollmann","year":"1983"},{"key":"ref26","series-title":"J Vet Pharmacol Ther","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2885.1987.tb00113.x","article-title":"Pharmacokinetics of propafenone in the dog after single-dose intravenous administration","volume":"10","author":"Puigdemont","year":"1987"},{"key":"ref27","series-title":"J Pharmacol Methods","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0160-5402(90)90035-J","article-title":"Propafenone kinetics in the horse: comparative analysis of compartmental and noncompartmental models","volume":"23","author":"Puigdemont","year":"1990"},{"key":"ref28","series-title":"Eur Soc Cardiol","first-page":"526","article-title":"Plasma propafenone concentration in the evaluation of anti-arrhythmic efficacy","volume":"12","author":"Steurer","year":"1991"},{"key":"ref29","series-title":"Eur J Clin Pharmacol","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF00558075","article-title":"In vitro protein binding of propafenone in normal and uraemic human sera","volume":"36","author":"Chan","year":"1989"},{"key":"ref30","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/01.CIR.66.6.1190","article-title":"Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine","volume":"66","author":"Karagueuzian","year":"1982"},{"key":"ref31","series-title":"J Anal Toxicol","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/jat\/27.8.595","article-title":"Fatal propafenone overdoses: case reports and a review of the literature","volume":"27","author":"Clarot","year":"2003"},{"key":"ref32","series-title":"Cardiology of the horse","first-page":"177","article-title":"Arrhythmias","author":"Reef","year":"1999"},{"key":"ref33","series-title":"J Cardiovasc Electrophysiol","first-page":"S69","article-title":"Mechanisms of pharmacologic cardioversion of atrial fibrillation by class I drugs","volume":"9","author":"Allessie","year":"1998"},{"key":"ref34","series-title":"Ann Pharacother","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1177\/106002809202600714","article-title":"Propafenone-induced liver injury","volume":"26","author":"Spinler","year":"1992"},{"key":"ref35","series-title":"Dig Dis Sci","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1023\/A:1021943930424","article-title":"Propafenone toxicity: report of two new cases","volume":"48","author":"Cocozzella","year":"2003"},{"key":"ref36","series-title":"Recenti Prog Med","first-page":"197","article-title":"Acute cholestatic hepatitis caused by propafenone. Report of a case and review of the literature [in Italian]","volume":"92","author":"Gandolfi","year":"2001"},{"key":"ref37","series-title":"Am J Med Sci","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00000441-200008000-00016","article-title":"Propafenone-induced ataxia: report of three cases","volume":"320","author":"Odeh","year":"2000"},{"key":"ref38","series-title":"Int J Dermatol","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1365-4632.2004.02311.x","article-title":"Propafenone-induced acute generalized exanthematous pustulosis","volume":"44","author":"Huang","year":"2005"},{"key":"ref39","series-title":"Int J Cardiol","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijcard.2005.01.033","article-title":"Broad complex tachycardia during treatment of atrial fibrillation with a Ic antiarrhythmic drug: ventricular or supraventricular proarrhythmia?","volume":"107","author":"Wiesfeld","year":"2006"},{"key":"ref40","series-title":"CJEM","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1017\/S1481803500009635","article-title":"Bicarbonate therapy for unstable propafenone-induced wide complex tachycardia","volume":"6","author":"Brubacher","year":"2004"},{"key":"ref41","series-title":"Bratisl Lek Listy","first-page":"14","article-title":"Acute toxicity of propafenone in a case of suicidal attempt","volume":"105","author":"Stancak","year":"2004"},{"key":"ref42","series-title":"Clin Drug Investig","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2165\/00044011-200727070-00008","article-title":"Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin","volume":"27","author":"Unal","year":"2007"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/70\/2\/ajvr.70.2.223.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/70\/2\/ajvr.70.2.223.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/70\/2\/ajvr.70.2.223.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:20:17Z","timestamp":1741350017000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/70\/2\/ajvr.70.2.223.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":42,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.70.2.223","relation":{},"ISSN":["0002-9645"],"issn-type":[{"value":"0002-9645","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}